Mgr. Renata Chloupková
Analyst, Institute of Biostatistics and Analyses
Correspondence Address:
Kamenice 753/5, 625 00 Brno
E‑mail: |
---|
Total number of publications: 84
2019
-
Screeningové programy onkologických onemocnění a aktuální výsledky adresného zvaní v České republice
Year: 2019, type:
-
Sequential therapy with bevacizumab and EGFR inhibitors for metastatic colorectal carcinoma: a national registry-based analysis
CANCER MANAGEMENT AND RESEARCH, year: 2019, volume: 11, edition: 2019, DOI
-
Tyrosine kinase inhibitors in the first-line treatment for metastatic nonclear cell renal carcinoma: A retrospective analysis of a national database
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, year: 2019, volume: 37, edition: 4, DOI
-
Vyhodnocení adresného zvaní českých občanů do screeningových programů
Časopis lékařů českých, year: 2019, volume: 158, edition: 3-4
2018
-
Hodnocení adresného zvaní občanů do screeningových programů v ČR
Year: 2018, type: Appeared in Conference without Proceedings
-
Chronic Inflammation as a Potential Predictive Factor of Nivolumab Therapy in Non-small Cell Lung Cancer
Anticancer Research, year: 2018, volume: 38, edition: 12, DOI
-
Impact of Delayed Addition of Anti-EGFR Monoclonal Antibodies on the Outcome of First-Line Therapy in Metastatic Colorectal Cancer Patients: a Retrospective Registry-Based Analysis
Targeted Oncology, year: 2018, volume: 13, edition: 6, DOI
-
Pazopanib for Metastatic Renal Cell Carcinoma: A Registry-based Analysis of 426 Patients
Anticancer Research, year: 2018, volume: 38, edition: 1, DOI
-
Program screeningu karcinomu prsu v datech
Year: 2018, type: Appeared in Conference without Proceedings
-
Trastuzumab v neoadjuvantní léčbě HER2+ karcinomu prsu – 5leté zkušenosti z onkologické kliniky 1. LF UK a VFN
Klinická onkologie, year: 2018, volume: 31, edition: 3, DOI